At GWCIM, we offer NAD+ as an intramuscular injection rather than an IV infusion
Target Consumer Segments Adults With Weight Management Goals (2550) : men and women seeking therapeutic supplementation to support appetite control, metabolic balance, and sustainable weight loss Adults With Pre-diabetes Or Type 2 Diabetes (3060) : individuals requiring preventative and therapeutic support for blood sugar regulation and improved insulin sensitivity Obese And Overweight Consumers (2555) : patients and health-conscious adults addressing obesity-related health risks who benefit from GLP-1 boosting supplementation Seniors (60+) : older adults managing metabolic slowdown, reduced satiety, and elevated cardiovascular risks who require preventative support for healthy aging Fitness Enthusiasts (2040) : active adults seeking appetite regulation, energy balance, and weight management supplementation to complement their fitness routines Patients In Recovery : individuals post-treatment or managing chronic metabolic conditions who need therapeutic nutritional support for stabilization and rehabilitation Regional Consumer Demand North America Market Insight : Rising awareness of weight management and metabolic health is driving demand for GLP-1 supplements, particularly in the wellness and fitness sectors
Overall, the efficacy of semaglutide in weight reduction was demonstrated in patients both with concomitant T2Dspecifically in STEP 2 [39], which included only patients with T2D, as well as in STEP 6, 7, and 10, which included both patients with and without T2D [41,42,43]and without diabetes (STEP 1, 3, 4, 5, 8, and 9) [13, 38, 40, 44,45,46]
Artesunate is a promising anti-fibrotic drug candidate, but its clinical application is hindered by limited absorption
GH peaks around 30-40 minutes after the shot and returns to baseline within 2-3 hours
There is no evidence that semaglutide itself causes missed periods
